NBIX Financial Facts
Income (loss) from operations: -38.44MTotal revenues: 0
See Full Income Statement
Property and equipment, net: 6.18M
Other current assets: 4.85M
See Full Balance Sheet
Neurocrine Biosciences Inc. (NBIX) Earnings
|
Expand Research on NBIX
| Next EPS Date | 8/4/26 | EPS Growth Rate | -4.8% |
|---|---|---|---|
| Average EPS % Beat Rate | +43.8% | Revenue Growth Rate | +26.1% |
| Average % Move 1-Wk after EPS | -1.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/4/26  |
Q226 | N/A | $1.57 | N/A | N/A | $866.7M | = | N/A | N/A | ||
| 5/5/26 | Q126 | $1.94 | $1.17 | +$0.77 | $811M | $766.85M | = |  | | Details | |
| 2/11/26 | Q425 | $1.88 | $1.86 | +$0.02 | $805.5M | $802.45M | = | | | Details | |
| 10/28/25 | Q325 | $2.17 | $1.59 | +$0.58 | $794.9M | $748.62M | = | | | Details | |
| 7/30/25 | Q225 | $1.65 | $0.96 | +$0.69 | $687.5M | $653.32M | = | | | Details | |
| 5/5/25 | Q125 | $0.70 | $0.77 | -$0.07 | $572.6M | $593.71M | = | | | Details | |
| 2/6/25 | Q424 | $1.69 | $1.57 | +$0.12 | $627.7M | $630.01M | = | | | Details | |
| 10/30/24 | Q324 | $1.81 | $1.52 | +$0.29 | $622.1M | $600.97M | = | | | Details |
